Product_(approval_date,_company)#Revenue_in_million_U.S._dollars
Sovaldi_(Dec_06_Gilead_Sciences)#5221
Tecfidera_(Mar_27_Biogen_Idec)#3299
Kadcyla_(Feb_22_Roche)#3049
Imbruvica_(Nov_13_Pharmacyclics)#2453
Tivicay_(Aug_12_GlaxoSmithKline)#2132
Breo_Ellipta_(May_10_GlaxoSmithKline)#1332
Anoro_Ellipta_(Dec_18_GlaxoSmithKline)#1242
Gazyva_(Nov_01_Roche)#1149
Brintellix_(Sep_30_Takeda)#875
Xofigo_(May_15_Bayer)#829
